DCM
LLY icon

Decatur Capital Management’s Eli Lilly LLY Stock Holding History

Decatur Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.76M Buy
7,301
+5
+0.1% +$5.11K 2.97% 10
2026
Q1 		$6.71M Sell
7,296
-116
-2% -$118K 3.07% 10
2025
Q4 		$7.97M Sell
7,412
-383
-5% -$366K 3.24% 9
2025
Q3 		$5.95M Buy
7,795
+15
+0.2% +$11.2K 2.36% 12
2025
Q2 		$6.06M Hold
7,780
– – 2.66% 11
2025
Q1 		$6.43M Buy
7,780
+13
+0.2% +$10.8K 3.33% 8
2024
Q4 		$6M Sell
7,767
-115
-1% -$95.2K 2.73% 10
2024
Q3 		$6.98M Buy
7,882
+10
+0.1% +$8.99K 3.22% 7
2024
Q2 		$7.13M Buy
7,872
+187
+2% +$150K 3.46% 7
2024
Q1 		$5.98M Sell
7,685
-78
-1% -$55.5K 3.25% 7
2023
Q4 		$4.53M Buy
7,763
+2,233
+40% +$1.3M 2.71% 8
2023
Q3 		$2.97M Hold
5,530
– – 2.14% 9
2023
Q2 		$2.59M Buy
+5,530
New +$2.32M 1.77% 14

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Decatur Capital Management's LLY Position: Q2 2026 in Review

Decatur Capital Management increased its Eli Lilly (LLY) stake by 0.07% in Q2 2026, buying an estimated $5.11K and bringing the position to 7,301 shares worth $8.76M. The position accounts for 2.97% of the portfolio, ranked #10.

Decatur Capital Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Decatur Capital Management held 7,301 shares of Eli Lilly worth $8.76M as of Q2 2026.
  • Decatur Capital Management bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 2.97% of Decatur Capital Management's portfolio in Q2 2026, its #10 holding.
  • Decatur Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Decatur Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.